Literature DB >> 25550849

MicroRNA-139-3p indicates a poor prognosis of colon cancer.

Xiaojing Liu1, Bensong Duan2, Yuanyuan Dong3, Chengzhi He2, Hongmei Zhou4, Haihui Sheng4, Hengjun Gao5, Xizhi Zhang1.   

Abstract

MicroRNAs (miRNAs) play an important role in the regulation of gene expression and are involved in almost biological procession. Recently, miR-139-5p has been reported to be downregulated in some types of cancer, and inhibits cancer cell invasion and metastasis. However, there are few reports on the role of miR-139-3p in cancer. In this study, we examined the expression level of miR-139-3p in 63 pairs of colon cancer and adjacent paracancerous tissues using quantitative reverse transcription PCR. The levels of miR-139-3p in colon cancer tissues were significantly lower than those in adjacent noncancerous tissues. There was an inverse correlation between the level of miR-139-3p and patient's age. Lower level of miR-139-3p was significantly associated with poor overall survival, especially in patients with TNM stages I and II. In conclusion, miR-139-3p has potential as a prognostic biomarker for colon cancer. Further prospective studies are required to validate this result.

Entities:  

Keywords:  MicroRNA; colon cancer; miR-139; miR-139-3p; prognosis

Mesh:

Substances:

Year:  2014        PMID: 25550849      PMCID: PMC4270559     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  33 in total

Review 1.  MicroRNAs in cancer: biomarkers, functions and therapy.

Authors:  Josie Hayes; Pier Paolo Peruzzi; Sean Lawler
Journal:  Trends Mol Med       Date:  2014-07-12       Impact factor: 11.951

Review 2.  Colorectal cancer and the 7th revision of the TNM staging system: review of changes and suggestions for uniform pathologic reporting.

Authors:  F L Obrocea; Maria Sajin; Elena Cristina Marinescu; D Stoica
Journal:  Rom J Morphol Embryol       Date:  2011       Impact factor: 1.033

3.  HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells.

Authors:  Wei Bao; Hai-Jing Fu; Qiao-Sheng Xie; Lei Wang; Rui Zhang; Zhang-Yan Guo; Jing Zhao; Yan-Ling Meng; Xin-Ling Ren; Tao Wang; Qing Li; Bo-Quan Jin; Li-Bo Yao; Rui-An Wang; Dai-Ming Fan; Si-Yi Chen; Lin-Tao Jia; An-Gang Yang
Journal:  Gastroenterology       Date:  2011-09-16       Impact factor: 22.682

4.  MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells.

Authors:  Hua-Nan Luo; Zheng-Hui Wang; Ying Sheng; Qing Zhang; Jing Yan; Jin Hou; Kang Zhu; Ying Cheng; Ying-Long Xu; Xiang-Hong Zhang; Min Xu; Xiao-Yong Ren
Journal:  Med Oncol       Date:  2013-12-07       Impact factor: 3.064

5.  Serum miR-200c and clinical outcome of patients with advanced esophageal squamous cancer receiving platinum-based chemotherapy.

Authors:  Hong Yu; Bensong Duan; Lin Jiang; Mei Lin; Haihui Sheng; Junxing Huang; Hengjun Gao
Journal:  Am J Transl Res       Date:  2013-12-01       Impact factor: 4.060

6.  Prognostic value of miR-221-3p, miR-342-3p and miR-491-5p expression in colon cancer.

Authors:  Kun Tao; Jing Yang; Zhenhua Guo; Yuemei Hu; Haihui Sheng; Hengjun Gao; Hongyu Yu
Journal:  Am J Transl Res       Date:  2014-07-18       Impact factor: 4.060

7.  MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1.

Authors:  Mingxu Song; Yuan Yin; Jiwei Zhang; Binbin Zhang; Zehua Bian; Chao Quan; Leyuan Zhou; Yaling Hu; Qifeng Wang; Shujuan Ni; Bojian Fei; Weili Wang; Xiang Du; Dong Hua; Zhaohui Huang
Journal:  Protein Cell       Date:  2014-08-23       Impact factor: 14.870

8.  Age-related changes in microRNA levels in serum.

Authors:  Nicole Noren Hooten; Megan Fitzpatrick; William H Wood; Supriyo De; Ngozi Ejiogu; Yongqing Zhang; Julie A Mattison; Kevin G Becker; Alan B Zonderman; Michele K Evans
Journal:  Aging (Albany NY)       Date:  2013-10       Impact factor: 5.682

9.  microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer.

Authors:  Lijing Zhang; Yujuan Dong; Nana Zhu; Ho Tsoi; Zengren Zhao; Chung Wah Wu; Kunning Wang; Shu Zheng; Simon Sm Ng; Francis Kl Chan; Joseph Jy Sung; Jun Yu
Journal:  Mol Cancer       Date:  2014-05-26       Impact factor: 27.401

Review 10.  MicroRNAs: novel players in cancer diagnosis and therapies.

Authors:  Aaron L Oom; Brock A Humphries; Chengfeng Yang
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411

View more
  29 in total

1.  The silence of p66(Shc) in HCT8 cells inhibits the viability via PI3K/AKT/Mdm-2/p53 signaling pathway.

Authors:  Ling Zhang; Shengtao Zhu; Xuesen Shi; Weihong Sha
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  MiR-199a inhibits the angiogenic potential of endometrial stromal cells under hypoxia by targeting HIF-1α/VEGF pathway.

Authors:  Lan Dai; Weihua Lou; Jie Zhu; Xingchen Zhou; Wen Di
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  hsa_circ_0000218/hsa-miR-139-3p/SOX4 regulatory feedback circuit influences the proliferation and apoptosis of gastric cancer cells.

Authors:  Ganlin Xia; Anxin Wang; Liangxue Li
Journal:  Cytotechnology       Date:  2022-01-10       Impact factor: 2.058

4.  Clinical value of serum miR-92 and miR-122 expression level combined with pulmonary ultrasound score in the prognosis of neonatal acute respiratory distress syndrome.

Authors:  Haiyan Hong; Binbin Fu; Renyuan Wang
Journal:  J Clin Lab Anal       Date:  2022-05-25       Impact factor: 3.124

5.  MicroRNA-139 inhibits the proliferation, migration and invasion of gastric cancer cells by directly targeting ρ-associated protein kinase 1.

Authors:  Xuechun Yu; Chaojian Ma; Ling Fu; Jingwu Dong; Jie Ying
Journal:  Oncol Lett       Date:  2018-02-13       Impact factor: 2.967

Review 6.  MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer.

Authors:  Rui Yi; Yao Li; Fei-Liang Wang; Gang Miao; Ruo-Mei Qi; Yan-Yang Zhao
Journal:  World J Gastrointest Oncol       Date:  2016-04-15

Review 7.  MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers.

Authors:  Ganji Purnachandra Nagaraju; Appiya Santharam Madanraj; Sheik Aliya; Balney Rajitha; Olatunji Boladale Alese; Ekamber Kariali; Afroz Alam; Bassel F El-Rayes
Journal:  Tumour Biol       Date:  2015-11-04

8.  MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.

Authors:  Jianan Chen; Yan Yu; Xiaolong Chen; Yuting He; Qiuyue Hu; Hongqiang Li; Qicai Han; Fang Ren; Juan Li; Chao Li; Jie Bao; Zhigang Ren; Zhenfeng Duan; Guangying Cui; Ranran Sun
Journal:  Cell Prolif       Date:  2018-08-13       Impact factor: 6.831

Review 9.  MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer.

Authors:  Lina Cekaite; Peter W Eide; Guro E Lind; Rolf I Skotheim; Ragnhild A Lothe
Journal:  Oncotarget       Date:  2016-02-09

10.  Altered Expressions of miR-1238-3p, miR-494, miR-6069, and miR-139-3p in the Formation of Chronic Brucellosis.

Authors:  Ferah Budak; Salih Haldun Bal; Gulcin Tezcan; Halis Akalın; Guher Goral; Haluk Barbaros Oral
Journal:  J Immunol Res       Date:  2016-09-19       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.